Intrinsic Value of S&P & Nasdaq Contact Us

Nkarta, Inc. NKTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.60
+843.2%

Nkarta, Inc. (NKTX) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 10 recommend buying, 2 recommend holding, and 0 recommend selling.

The analyst consensus price target for NKTX is $21.60, representing a +843.2% upside from the current price of $2.29. Price targets range from a low of $15.00 to a high of $36.00.

Analyst Consensus — NKTX

Buy
Strong Buy
1
Buy
9
Hold
2
Sell
0
Strong Sell
0
12 analysts
Price Targets
Consensus$21.60
High$36.00
Low$15.00
Median$16.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message